People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Moximed, Inc | — | Other Health Care | Series C | $187.8M | $499.3M | 2009 |
| ExploraMed NC7, Inc. | — | Other Health Care | Series C | $181.5M | $751.6M | 2017 |
| Ancora Heart, Inc. | — | Other Health Care | Series C | $151.3M | $1.4B | 2010 |
| Neotract Inc | — | Other Health Care | Series C | $117.5M | $293.0M | 2009 |
| Revelle Aesthetics, Inc. | — | Other Health Care | Series C | $50.0M | $1.1B | 2020 |
| Vibrynt, INc | — | Other Health Care | Series A | $14.3M | $55.5M | 2011 |
| ExploraMed V, L.L.C. | — | Other Health Care | Series A | $8.8M | $176.7M | 2017 |
Robert W. Croce at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert W. Croce on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 4 | 24 |
| Joshua Makower | 4 | 10 |
| Joshua W. Makower | 4 | 4 |
| Robert Anderson | 3 | 24 |
| John Nehra | 3 | 11 |
| ROBERT CROCE | 3 | 7 |
| Robert K. Anderson | 3 | 6 |
| Ryan W. Drant | 3 | 4 |
| David Amerson | 2 | 5 |
| Earl A. Bright II | 2 | 2 |
| Nina W Richardson | 2 | 2 |
| Joshua A. Makower | 2 | 2 |
| John W. Nehra | 2 | 2 |
| Christopher Gleason | 1 | 35 |
| Henry A. Plain, Jr. | 1 | 7 |
| Michael Carusi | 1 | 7 |
| Heather Preston | 1 | 6 |
| Lewis C. Pell | 1 | 5 |
| William Facteau | 1 | 5 |
| Henry A. Plain | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.